Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study

OBJECTIVE White matter lesions are often seen on MR scans of elderly non-demented and demented people. They are attributed to degenerative changes of small vessels and are implicated in the pathogenesis of cognitive decline and dementia. There is evidence that especially periventricular white matter lesions are related to cognitive decline, whereas subcortical white matter lesions may be related to late onset depression. The frequency distribution of subcortical and periventricular white matter lesions according to age and sex reported. METHODS A total of 1077 subjects aged between 60–90 years were randomly sampled from the general population. All subjects underwent 1.5T MR scanning; white matter lesions were rated separately for the subcortical region and the periventricular region. RESULTS Of all subjects 8% were completely free of subcortical white matter lesions, 20% had no periventricular white matter lesions, and 5% had no white matter lesions in either of these locations. The proportion with white matter lesions increased with age, similarly for men and women. Women tended to have more subcortical white matter lesions than men (total volume 1.45 ml v 1.29 ml; p=0.33), mainly caused by marked differences in the frontal white matter lesion volume (0.89 ml v 0.70 ml; p=0.08). Periventricular white matter lesions were also more frequent among women than men (mean grade 2.5 v 2.3; p=0.07). Also severe degrees of subcortical white matter lesions were more common in women than in men (OR 1.1; 95% confidence interval (95% CI) 0.8–1.5) and periventricular white matter lesions (OR 1.2; 95% CI 0.9–1.7), albeit that none of these findings were statistically significant. CONCLUSIONS The prevalence and the degree of cerebral white matter lesions increased with age. Women tended to have a higher degree of white matter lesions than men. This may underlie the finding of a higher incidence of dementia in women than in men, particularly at later age.

[1]  A. Hofman,et al.  Atrial fibrillation and the risk of cerebral white matter lesions , 2000, Neurology.

[2]  S. Lovestone.  Diabetes and dementia , 1999, Neurology.

[3]  A. Hofman,et al.  Incidence and risk of dementia. The Rotterdam Study. , 1998, American journal of epidemiology.

[4]  K. Marder,et al.  Estrogen to treat Alzheimer’s disease: Too little, too late? , 2000, Neurology.

[5]  A. Hofman,et al.  Raised blood pressure and plasma noradrenaline concentrations in teenagers and young adults selected from an open population. , 1979, British medical journal.

[6]  J. O'Brien,et al.  White matter lesions in depression and Alzheimer's disease , 1996, British Journal of Psychiatry.

[7]  F. Fazekas,et al.  Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. , 1992, Archives of neurology.

[8]  W. H. Jones.  Four Treatises of Theophrastus von Hohenheim called Paracelsus , 1942, Nature.

[9]  Bertil Olsson,et al.  Cerebral Lesions on Magnetic Resonance Imaging, Heart Disease, and Vascular Risk Factors in Subjects Without Stroke: A Population‐Based Study , 1994, Stroke.

[10]  B. McEwen,et al.  Ovarian steroids and the brain , 1997, Neurology.

[11]  A Hofman,et al.  Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly , 1999, Neurology.

[12]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[13]  A. Mooradian.  Antioxidant properties of steroids , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  E. Niki,et al.  Estrogens as antioxidants. , 1990, Methods in enzymology.

[15]  F. Fazekas,et al.  Neuropsychologic correlates of MRI white matter hyperintensities , 1993, Neurology.

[16]  M. Nakano,et al.  Stopped-flow investigation of antioxidant activity of estrogens in solution. , 1990, Biochimica et biophysica acta.

[17]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[18]  L Ketonen,et al.  Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? , 1987, Journal of neurology, neurosurgery, and psychiatry.

[19]  E M Wijsman,et al.  Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. , 1996, American journal of human genetics.

[20]  A. Hofman,et al.  Cerebral white matter lesions and cognitive function: The Rotterdam scan study , 2000, Annals of neurology.

[21]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[22]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[23]  B Horwitz,et al.  White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. , 1990, Archives of neurology.

[24]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[25]  D. Murphy,et al.  Protection against Alzheimer's disease? , 1996, The Lancet.

[26]  A. Hofman,et al.  Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study , 2000, Journal of Neurology.

[27]  J F Toole,et al.  Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. , 1996, Stroke.

[28]  Schechter Dc.  St. Vitus' dance and rheumatic disease. , 1975 .

[29]  Klaus P. Ebmeier,et al.  Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? , 1988, Journal of neurology, neurosurgery, and psychiatry.

[30]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.

[31]  T. Erkinjuntti,et al.  White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. , 1995, Stroke.

[32]  A. Hofman,et al.  Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.

[33]  A Hofman,et al.  A follow‐up study of blood pressure and cerebral white matter lesions , 1999, Annals of neurology.

[34]  M. Mattson,et al.  Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons , 1996, Journal of neurochemistry.

[35]  F. de Leeuw,et al.  Cognitive correlates of cerebral white matter changes. , 1998, Journal of neural transmission. Supplementum.

[36]  D. Schechter.  St. Vitus' dance and rheumatic disease. , 1975, New York state journal of medicine.

[37]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[38]  L. S. King.  Fighting Infection: Conquests of the 20th Century , 1977 .

[39]  E. Niki,et al.  [34] Estrogens as antioxidants , 1990 .

[40]  O Almkvist,et al.  White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. , 1992, Archives of neurology.

[41]  F. Fazekas,et al.  Vascular risk factors in dementia , 2000, Journal of Neurology.

[42]  Paracelsus,et al.  Four Treatises of Theophrastus Von Hohenheim Called Paracelsus , 1942 .

[43]  H Morgenstern,et al.  Development of dementing illnesses in an 80‐year‐old volunteer cohort , 1989, Annals of neurology.

[44]  Frederik Barkhof,et al.  White Matter Changes on CT and MRI: An Overview of Visual Rating Scales , 1998, European Neurology.

[45]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[46]  A. Hofman,et al.  1H chemical shift imaging of the human brain at age 60–90 years reveals metabolic differences between women and men , 1999, Magnetic resonance in medicine.

[47]  C. Behl,et al.  Increased antioxidant enzyme activity in amyloid beta protein-resistant cells , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  Matthijs Oudkerk,et al.  Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. , 2000 .